Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants.

Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S78-86. No abstract available.

PMID:
14575940
2.

The Women's Health Initiative recruitment methods and results.

Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, Rossouw JE.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S18-77. No abstract available.

PMID:
14575939
3.

The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures.

Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S107-21. No abstract available.

PMID:
14575943
4.

Implementation of the Women's Health Initiative study design.

Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S5-17. No abstract available.

PMID:
14575938
5.

The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants.

Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels-Tinker L, Howard B, Ockene J.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S87-97. No abstract available.

PMID:
14575941
6.

The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants.

Jackson RD, LaCroix AZ, Cauley JA, McGowan J.

Ann Epidemiol. 2003 Oct;13(9 Suppl):S98-106. No abstract available.

PMID:
14575942
7.

Observational studies, clinical trials, and the women's health initiative.

Prentice RL.

Lifetime Data Anal. 2007 Dec;13(4):449-62. Epub 2007 Oct 18. Review.

PMID:
17943443
8.

After the Women's Health Initiative: decision making and trust of women taking hormone therapy.

Schonberg MA, Davis RB, Wee CC.

Womens Health Issues. 2005 Jul-Aug;15(4):187-95.

PMID:
16051110
9.

Negative Women's Health Initiative findings stir consternation, debate among researchers.

Twombly R.

J Natl Cancer Inst. 2006 Apr 19;98(8):508-10. No abstract available. Erratum in: J Natl Cancer Inst. 2006 Jun 7;98(11):735.

10.

Tipping the balance: the WHI study and the benefits and risks of hormone replacement therapy. Women's Health Initiative.

Collins JA.

J Obstet Gynaecol Can. 2002 Sep;24(9):683-8. English, French. No abstract available.

PMID:
12360360
11.

Rashomon revisited: two views of monitoring the Women's Health Initiative trials.

Goodman SN.

Clin Trials. 2007;4(3):205-6. No abstract available.

PMID:
17715245
12.

Research staff turnover and participant adherence in the Women's Health Initiative.

Jackson M, Berman N, Huber M, Snetselaar L, Granek I, Boe K, Milas C, Spivak J, Chlebowski RT.

Control Clin Trials. 2003 Aug;24(4):422-35.

PMID:
12865036
13.
14.
15.

WISDOM: history and early demise - was it inevitable?

Vickers M, Meade T, Darbyshire J.

Climacteric. 2002 Dec;5(4):317-25.

PMID:
12626209
16.

Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.

Rigby AJ, Ma J, Stafford RS.

Menopause. 2007 Sep-Oct;14(5):853-8.

PMID:
17429334
17.

Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.

Wittes J, Barrett-Connor E, Braunwald E, Chesney M, Cohen HJ, Demets D, Dunn L, Dwyer J, Heaney RP, Vogel V, Walters L, Yusuf S.

Clin Trials. 2007;4(3):218-34.

PMID:
17715247
19.

Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.

Derry PS.

Womens Health Issues. 2004 Nov-Dec;14(6):212-9. Review.

PMID:
15589771
20.

Postmenopausal hormone replacement therapy after the Women's Health Initiative.

Doty TJ.

JAAPA. 2005 Jan;18(1):30-7; quiz 39-40. Review. No abstract available.

PMID:
15675117
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk